SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls

Hemodialysis (HD) patients have an increased risk of severe SARS-CoV-2 infection. In this study, we assess the impact of a third vaccine dose (3D) on antibody levels and T cell response in HD patients and a healthy control group in a prospective cohort study consisting of 60 HD patients and 65 healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Benedikt, Rubey, Harald, Gromann, Martin, Knopf-Völkerer, Astrid, Hemedi, Boris, Zehetmayer, Sonja, Kirsch, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145549/
https://www.ncbi.nlm.nih.gov/pubmed/35632450
http://dx.doi.org/10.3390/vaccines10050694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145549/
https://www.ncbi.nlm.nih.gov/pubmed/35632450
http://dx.doi.org/10.3390/vaccines10050694

Ejemplares similares